1. Home
  2. PDSB vs SACH Comparison

PDSB vs SACH Comparison

Compare PDSB & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.88

Market Cap

49.5M

Sector

Health Care

ML Signal

HOLD

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

HOLD

Current Price

$1.00

Market Cap

52.0M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDSB
SACH
Founded
2005
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
49.5M
52.0M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
PDSB
SACH
Price
$0.88
$1.00
Analyst Decision
Strong Buy
Hold
Analyst Count
2
3
Target Price
$9.00
$2.00
AVG Volume (30 Days)
592.3K
265.9K
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
20.10%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,906,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$0.80
52 Week High
$2.20
$1.40

Technical Indicators

Market Signals
Indicator
PDSB
SACH
Relative Strength Index (RSI) 49.68 41.27
Support Level $0.86 $0.99
Resistance Level $0.93 $1.05
Average True Range (ATR) 0.07 0.05
MACD -0.00 -0.01
Stochastic Oscillator 11.26 3.04

Price Performance

Historical Comparison
PDSB
SACH

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

Share on Social Networks: